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Abstract  Congenital  long  QT  syndrome  (cLQTS)  is  a  channelopathy  characterized  by  ventricu-
lar repolarization  disturbances.  The  clinical  presentation  varies  from  an  asymptomatic  patient
to a  patient  with  recurrent  syncopes,  seizures,  and  even  sudden  death.  This  article  aims  to  con-
tribute to  medical  knowledge  of  this  relatively  new  disease  in  newborns,  so  that  early  diagnoses
with timely  treatments  can  be  made.  Genotypically,  there  are  13  types  of  cLQTS,  which  are
classiﬁed by  phenotype  into:  Romano-Ward,  Jervell-Lange-Nielsen,  Andersen-Tawil  and  Timo-
thy. We  present  the  following  case  of  a  newborn  who  presented  clinical  sustained  bradycardia
on her  ﬁrst  day  of  life,  who  was  admitted  to  the  Neonatal  Intensive  Care,  where  her  assessment
and imaging  studies  guided  us  to  a  cLQTS  diagnosis.  The  patient  recovered  satisfactorily,  and
was discharged  with  outpatient  follow-up  without  complications.
All abnormal  QT  patients  should  be  assessed  with  an  integral  clinical  report,  Holter  ana-
lyzer, and  a  stress  test.  Ideally,  a  genetic  screening,  which  can  have  a  great  impact  on  the
treatment,  should  be  done.  Although  it  is  relatively  uncommon,  recognition  of  this  entity  is
important  because  it  can  prevent  death.  We  present  a  case  of  cLQTS  diagnosis,  with  approach
and treatment.
©  2014  Universidad  Autónoma  de  Nuevo  León.  Published  by  Masson  Doyma  México  S.A.  All  rights
reserved.
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eonatal  arrhythmias  represent  a relatively  common  prob-
em  encountered  by  pediatricians.  However,  because  most
f  them  turn  out  to  be  benign,  it  is  vital  to  master  the  diag-
ostic  approach  which  allows  the  identiﬁcation  of  patients
ho  may  be  at  risk  of  death.1 cLQTS  is  a  rare  genetic  entity
rom  the  denominated  channelopathies,  characterized  by
asson Doyma México S.A. All rights reserved.
Long  QT  syndrome  in  a  neonate  47
Table  1  List  of  medications  which  prolong  the  QT  interval.
Amantadine
Azithromycin/erythromycin
Chloral  hydrate
Ciproﬂoxacin
Cisapride
Domperidone
Furosemide
Metronidazole
Trimethoprim/Sulfamethoxazole
Figure  1  ECG  tracing  where  the  sinus  rythym  is  shown  using
Bazett’s  formula  and  ﬁnding  an  extension  of  corrected  QT.
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mutations  in  ion  channels  or  their  regulatory  proteins.  It  may
lead  to  sudden  death  because  of  ventricular  repolarization
alterations,  which  is  seen  in  an  electrocardiogram  as  a  long
QT.2
This  alteration  is  the  main  cause  of  sudden  death  in
children;  this  is  secondary  to  a  malignant  ventricular  tachy-
cardia  (torsade  de  pointes),  and  can  be  often  be  provoked
by  a  series  of  conditions,  including  sudden  noise,  expo-
sure  to  cold  environments,  REM  sleep,  apnea,  leading  a
chemoreceptor  reﬂex  and  excitement.  It  is  also  important
to  obtain  a  detailed  family  history  and  pay  special  attention
to  sudden  deaths,  ventricular  ectopic  beats  and  seizures,
since  these  may  be  present  in  up  to  35%  of  the  seizures
induced  by  long  QT  and  could  be  mistaken  for  other  causes
of  seizures.3 Long  QT  acts  as  an  arrhythmogenic  substrate,
in  other  words,  it  requires  a  trigger  for  the  development  of
life-threatening  arrhythmias,  like  catecholamines  or  med-
ications  which  delay  QT  intervals  even  more.  Examples  of
these  medications  are  listed  in  Table  1.  A  genetic  study  in
all  patients  with  said  electrocardiographic  alteration  must
be  performed.4 We  present  a  clinical  case  of  a  newborn  with
an  abnormal  QT  prolongation.
Clinical case
Newborn  without  any  important  hereditary-family  history,
full  term  (38.6  weeks),  delivered  via  C-section  due  to  pelvic
presentation.  The  baby  only  required  the  initial  steps  of
reanimation,  with  an  Apgar  score  of  8/9.  A  newborn  rou-
tine  was  performed  registering  a  weight  of  3180  g,  49  cm
in  length  and  a  head  circumference  of  34  cm.  However,  a
few  hours  after  she  was  born,  we  detected  an  80  beat-per-
minute  bradycardia;  therefore,  we  decided  to  admit  her  to
the  Neonatal  Intensive  Care  Unit  (NICU).  During  physical
examination  we  recorded  a  heart  rate  of  74  beats-per-
minute,  a  respiratory  rate  of  54  breaths  per  minute,  blood
pressure  of  70/60  mm  Hg  and  SaO2 of  96%.  The  following
dysmorphias  were  found:  Head  with  wide  forehead,  wide
nasal  bridge,  low-implanted  ears,  thin  upper  lip,  enlarged
philtrum  and  micrognathia;  extremities  with  clinodactyly  in
the  5th  bilateral  ﬁnger  and  bilateral  transverse  crease;  skin
with  superﬁcial  scaling  on  the  face  and  scalp,  in  addition  to
eczematous  lesions  in  the  cheeks.  The  rest  of  the  physical
examination  was  normal.
The  admission  tests,  such  as  biochemical  proﬁle,  serum
electrolytes  and  complete  blood  count  showed  no  alter-
ations,  as  was  the  case  for  thoracic  X-rays  too.  The  ECG
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Figure  2  Calculation  of  the  corrected  QT  interval.
howed  sinus  bradycardia  and  we  measured  the  QT  using  the
azzet  formula  ﬁnding  a  long  QT  in  0.46  s  (Figs.  1  and  2).
The  patient  was  referred  to  Pediatric  Cardiology  where
hey  performed  an  echocardiogram,  reporting  a  permeable
oramen  ovale  of  2  mm  without  hemodynamic  repercussion
nd  performed  Holter  monitoring  presenting  non-sustained
inus  bradycardia  with  a  minimum  HR  of  58  (bpm)  and
lternating  T  waves.  With  this  data,  we  integrated  a
inus  bradycardia  with  long  QT  diagnosis  and  we  per-
ormed  consults  with  the  Genetics  Service  who  suspected
ndersen--Tawil  syndrome.  The  patient  received  treatment
ith  beta-blockers  (propranolol  3  mg/kg/day  orally  divided
nto  three  doses)  evolving  to  be  hemodynamically  stable
ithout  presenting  bradycardias.  We  considered  a  discharge
fter  13  days  of  life  outside  the  womb.
iscussion
hannelopathies  are  the  main  cause  of  congenital  arrhyth-
ias.  They  are  clinical  entities  in  which  there  is  a  mutation
f  the  genes  that  control  the  formation  of  transmembrane
rotein  responsible  for  regulating  the  amount  of  ions  that  go
hrough  the  cell.5 cLQTS  is  the  ﬁrst  channelopathy  described
nd  it  is  currently  considered  the  most  studied.  It  is  char-
cterized  by  a  ventricular  affectation  of  the  repolarization
hase  and  can  cause  sudden  death  by  polymorph  ventricular
achycardia  or  Torsade  de  Pointes.6 It  was  ﬁrst  described  in
957  by  Anton  Jervell  and  Fred  Lange  Nielsen,  who  linked syndrome  characterized  by  congenital  deafness,  syncope
nd  sudden  deaths  with  abnormal  prolongation  of  the  QT
nterval.  Later,  in  1964,  Romano  and  Ward  observed  similar
linical  characteristics  but  without  deafness.
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Clinical  presentation  varies  from  the  asymptomatic
atient,  to  the  patient  with  recurrent  syncopes,  seizure
rises  and  even  sudden  death.  Its  incidence  is  1/5000
ases.7,8 To  this  day,  over  500  mutations  have  been  iden-
iﬁed,  distributed  in  10  genes.  Genotypically,  there  are
3  types  of  cLQTS,  and  by  phenotype,  and  they  can  be
lassiﬁed  into  four  different  ways:  Romano-Ward,  Jervell-
ange-Nielsen,  Andersen-Tawil  and  Timothy.9
Corrected  QT  interval  measurement  was  obtained
sing  Bazett’s  formula,  dividing  the  QT  interval  by  the
quare  root  of  the  RR  interval  (cQT  =  QT/
√
RR) ideally
n  the  V5  or  DII  derivations.  In  diagnostic  orientation
chwartz’s  score  takes  into  account  electrocardiographic
ndings,  family  history  and  pathological  background  like
yncopes.10
In  this  clinical  case  we  phenotypically  describe  minor
acial  dysmorphias  such  as:  A  wide  forehead,  low-implanted
ars,  a  thin  upper  lip  and  micrognathia,  in  addition  to
linodactyly  in  the  5th  bilateral  ﬁnger,  which  ﬁts  better
n  a  description  of  cLQTS  7  or  Andersen  Tawil.  This  syn-
rome  currently  is  considered  to  be  a  different  entity  by
any  authors.  It  is  an  autosomal  dominant  alteration,  pre-
ominant  in  females  and  phenotypically  characterized  by
linodactyly,  hypertelorism,  wide  forehead  and  low  ear
mplantation.  Periodic  paralysis,  abnormal  skeletal  devel-
pment  and  ventricular  arrhythmias  may  occur.  Patients
end  to  be  asymptomatic,  or  minimally  symptomatic  despite
aving  frequent  extrasystoles  or  ventricular  tachycardia,
ypically  bidirectional  or  polymorphous.11
The  beta-blockers,  which  have  been  used  for  over  30
ears,  reduce  global  mortality  from  73%  to  6%.  Currently,
ll  patients  diagnosed  with  cLQTS,  with  or  without  clini-
al  symptoms,  must  receive  beta-blocker  treatment,  and
n  addition  the  patients  are  advised  to  avoid  rigorous  physi-
al  activity  and  administration  of  medications  which  prolong
epolarization  (Table  1).  In  patients  with  high  sudden-death
isk  an  implantable  automatic  deﬁbrillator  (IAD)  must  be
rescribed.  Within  this  group  we  included  patients  who
ere  symptomatic  despite  beta-blocker  treatment,  patients
ith  auriculo-ventricular  blocks,  those  with  documented
entricular  tachycardia  in  torsade  de  pointes,  and  those
atients  resuscitated  from  sudden  death.  It  should  also
e  prescribed  in  patients  with  an  excessively  long  cQT
≥0.5  s)  and  when  there  is  a  family  history  of  sudden
eaths.12
Aside  from  the  diagnostic  suspicion  to  which  phenotypic
eatures  may  lead  us,  all  abnormal  corrected  QT  patients
ust  be  approached  with  a  careful  clinical  history,  and
olter  monitoring.  We  recommend  a  follow-up  by  cardiolo-
ists  and  geneticists,  and  ideally,  a  genetic  screening,  which
1I.  Rodríguez-Balderrama  et  al.
an  have  an  impact  on  treatment  according  to  the  mutations
ound.
onclusion
he  importance  of  this  case  is  to  create  awareness  in
he  medical  community  of  these  new  pathologies  which
epresent  some  of  the  most  important  causes  of  neona-
al  arrhythmias;  however,  this  information,  in  addition  to
linical  history,  would  be  of  assistance  to  keep  in  mind
n  these  entities,  thus  having  early  diagnosis  and  treat-
ent,  avoiding  death.  Moreover,  we  stress  the  importance
f  complementing  it  with  geneticists  in  order  to  make  better
ecisions  with  the  families.  Even  though  cLQTS  is  relatively
are,  to  recognize  this  entity  is  of  great  importance,  because
arly  intervention  and  treatment  can  avoid  the  patient’s
udden  death.
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